Ians Toy con suprise bag opening

ny Build Greatest game in the world

Entertainment

View All
Future Farm Technologies Inc. (FFRMF) Announces Shareholder Meeting Dates and Update Regarding NexTech Spin-Off
June 20, 2018 0

Future Farm Technologies Inc. (FFRMF) Announces Shareholder Meeting Dates and Update Regarding NexTech Spin-Off

By FandomFare

Future Farm Technologies Inc. (FFRMF) Announces Shareholder Meeting Dates and Update Regarding NexTech Spin-Off Future Farm Announces Shareholder Meeting Dates and Update Regarding NexTech Spin-Off Future Farm Technologies Inc. (the...

Emblem to Launch Emblem Germany in Joint Venture with Acnos Pharma Emblem Corp. (EMC.V) (EMC-WT.V) (EMMBF) (“Emblem” or the “Company”), is pleased to announce that its Board of Directors has approved the Company’s formation of a joint venture under the name “Emblem Germany” (the “JV”) with German pharmaceutical wholesaler Acnos Pharma GmbH (“Acnos”) for the purpose of exporting Emblem branded cannabis products from Canada and importing them into Germany. Subject to completion of definitive agreements with respect to the JV, the JV will be 60% owned by Emblem and 40% owned by Acnos. With a population of approximately 82 million and federal health insurance coverage for medical cannabis, Germany’s adoption of cannabis has created one of the largest legal medical cannabis markets in the world. Subject to all applicable regulatory approvals and the entering into of definitive agreements setting out the terms of the JV, Emblem will supply the JV with cannabis oil for sale to German pharmacies, wholesalers and clinical labs for medical purposes. Teams from both companies are actively working to prepare and finalize definitive agreements setting out the terms of the JV, with the objective to commence export sales to Germany in 2019. “Forming Emblem Germany with Acnos supports our market development efforts to establish world-class distribution channels in the regions where cannabis use is federally legal,” said Nick Dean, President and CEO of Emblem. Upon completion, Emblem’s new 30,000 square foot Good Manufacturing Practices (“GMP”)-certified extraction facility will provide increased oil production capacity and significantly increase its extract and derivative product output to meet the expected demands of the German market. “We have been impressed with the approach and progress Emblem’s medical division has made in establishing cannabis as a pharmaceutical product,” said Dirk Simonis, CEO of Acnos. “Emblem’s medical product innovation strategy is aligned to ours. We believe that medical cannabis products in Germany should be prepared in metered dose-controlled formats that physicians will feel confidence prescribing. From our experience, the long view of the German medical market is focused on oil extracts vs combustible products.” John Stewart, President of Emblem’s Medical Division concurred, “Emblem was an early licensed producer to apply a pharmaceutical approach to the industry. We wanted to partner with a distributor with an equally strong background in the pharma industry. I am incredibly impressed with the knowledge and depth of understanding of the German pharmaceutical industry that Acnos brings.” Subsequent to completing a definitive agreement with Acnos, the export of products to Germany will be predicated upon Emblem satisfying applicable regulatory requirements for shipping cannabis products to Germany. This includes completion of Emblem’s GMP certified laboratory in Ontario and associated receipt of European Medical Agency GMP certification. Emblem will also require a Health Canada issued export permit and provisional import status from the German Bundesopiumstelle (Federal Narcotics Bureau) to import medical cannabis products into Germany. Emblem’s GMP facility is currently on target for completion in the fourth quarter with first shipments to Germany expected to occur in 2019. Mr. Dean added, “Today’s milestone further validates Emblem’s strategy for product innovation, leveraging the Company’s strong medical brand, and creating world-class distribution networks through relationships with the best partners in the business.” About Acnos Acnos Pharma GmbH is a pharmaceutical wholesaler based in Aachen, Germany. The company’s mission is to supply branded and non-branded medicines to pharmacies, wholesalers and other healthcare companies within the industry. By working closely with medical professionals and multinational manufacturers, Acnos strives for the highest and the latest standards and procedures to ensure the highest level of safety and quality. The quality management system and staff far exceed the industry’s regulatory requirements and standards to ensure flawless, traceable and monitored product paths from the manufacturer to the customer.

Emblem to Launch Emblem Germany in Joint Venture with Acnos Pharma Emblem Corp. (EMC.V) (EMC-WT.V) (EMMBF) (“Emblem” or the “Company”), is pleased to announce that its Board of Directors has approved the Company’s formation of a joint venture under the name “Emblem Germany” (the “JV”) with German pharmaceutical wholesaler Acnos Pharma GmbH (“Acnos”) for the purpose of exporting Emblem branded cannabis products from Canada and importing them into Germany. Subject to completion of definitive agreements with respect to the JV, the JV will be 60% owned by Emblem and 40% owned by Acnos. With a population of approximately 82 million and federal health insurance coverage for medical cannabis, Germany’s adoption of cannabis has created one of the largest legal medical cannabis markets in the world. Subject to all applicable regulatory approvals and the entering into of definitive agreements setting out the terms of the JV, Emblem will supply the JV with cannabis oil for sale to German pharmacies, wholesalers and clinical labs for medical purposes. Teams from both companies are actively working to prepare and finalize definitive agreements setting out the terms of the JV, with the objective to commence export sales to Germany in 2019. “Forming Emblem Germany with Acnos supports our market development efforts to establish world-class distribution channels in the regions where cannabis use is federally legal,” said Nick Dean, President and CEO of Emblem. Upon completion, Emblem’s new 30,000 square foot Good Manufacturing Practices (“GMP”)-certified extraction facility will provide increased oil production capacity and significantly increase its extract and derivative product output to meet the expected demands of the German market. “We have been impressed with the approach and progress Emblem’s medical division has made in establishing cannabis as a pharmaceutical product,” said Dirk Simonis, CEO of Acnos. “Emblem’s medical product innovation strategy is aligned to ours. We believe that medical cannabis products in Germany should be prepared in metered dose-controlled formats that physicians will feel confidence prescribing. From our experience, the long view of the German medical market is focused on oil extracts vs combustible products.” John Stewart, President of Emblem’s Medical Division concurred, “Emblem was an early licensed producer to apply a pharmaceutical approach to the industry. We wanted to partner with a distributor with an equally strong background in the pharma industry. I am incredibly impressed with the knowledge and depth of understanding of the German pharmaceutical industry that Acnos brings.” Subsequent to completing a definitive agreement with Acnos, the export of products to Germany will be predicated upon Emblem satisfying applicable regulatory requirements for shipping cannabis products to Germany. This includes completion of Emblem’s GMP certified laboratory in Ontario and associated receipt of European Medical Agency GMP certification. Emblem will also require a Health Canada issued export permit and provisional import status from the German Bundesopiumstelle (Federal Narcotics Bureau) to import medical cannabis products into Germany. Emblem’s GMP facility is currently on target for completion in the fourth quarter with first shipments to Germany expected to occur in 2019. Mr. Dean added, “Today’s milestone further validates Emblem’s strategy for product innovation, leveraging the Company’s strong medical brand, and creating world-class distribution networks through relationships with the best partners in the business.” About Acnos Acnos Pharma GmbH is a pharmaceutical wholesaler based in Aachen, Germany. The company’s mission is to supply branded and non-branded medicines to pharmacies, wholesalers and other healthcare companies within the industry. By working closely with medical professionals and multinational manufacturers, Acnos strives for the highest and the latest standards and procedures to ensure the highest level of safety and quality. The quality management system and staff far exceed the industry’s regulatory requirements and standards to ensure flawless, traceable and monitored product paths from the manufacturer to the customer.

June 20, 2018 0

Linux

View All
Red Hat Enterprise Linux 6.10 Now Available
June 20, 2018 0

Red Hat Enterprise Linux 6.10 Now Available

By FandomFare

Red Hat Enterprise Linux 6.10 Now Available Red Hat Enterprise Linux 6.10 We are pleased to announce the availability of Red Hat Enterprise Linux 6.10, the latest update to the...

Porteus Kiosk 4.7.0 is now available

Porteus Kiosk 4.7.0 is now available

June 18, 2018 0




Brazil’s Central Bank Builds Blockchain Platform To Share Data Among Regulators
June 21, 2018 0

Brazil’s Central Bank Builds Blockchain Platform To Share Data Among Regulators

By FandomFare

Brazil's Central Bank Builds Blockchain Platform To Share Data Among Regulators   The Brazilian regulatory authorities are set to use a blockchain-based technology platform developed by the IT department of...

Press Freedom Watchdog Accepts Donations In Cryptocurrency
June 21, 2018 0

Press Freedom Watchdog Accepts Donations In Cryptocurrency

By FandomFare

Press Freedom Watchdog Accepts Donations In Cryptocurrency   A nonprofit organization founded to promote free speech and freedom of the press has announced that it is accepting cryptocurrencies as donations...

WARHAMMER VERMINTIDE 2 ON XBOX ONE IN JULY
June 21, 2018 0

WARHAMMER VERMINTIDE 2 ON XBOX ONE IN JULY

By FandomFare

WARHAMMER VERMINTIDE 2 ON XBOX ONE IN JULY Skaven and Chaos Meet Joypad - Beta Starts Today STOCKHOLM, SWEDEN - June 21, 2018. Independent developer Fatshark today announced that the...

Mysteries of Summer Enter Black Desert Online
June 21, 2018 0

Mysteries of Summer Enter Black Desert Online

By FandomFare

Mysteries of Summer Enter Black Desert Online - Players can win fantastic prizes with the Mysteries of Summer eventsthat are inspired by Spielberg’s movie Ready Player One - Holiday resort Terrmian...

We didn’t know it then, but Squids Odyssey was actually designed for the Switch!  
June 21, 2018 0

We didn’t know it then, but Squids Odyssey was actually designed for the Switch!  

By FandomFare

We didn’t know it then, but Squids Odyssey was actually designed for the Switch!   Squids Odyssey is a pretty unique proposition: a tactical turn-based RPG with a twist of fling mechanism. The adventure...

The Journey Down: Chapter One is now available on Nintendo Switch and Chapter Two is around the corner!
June 21, 2018 0

The Journey Down: Chapter One is now available on Nintendo Switch and Chapter Two is around the corner!

By FandomFare

The Journey Down: Chapter One is now available on Nintendo Switch and Chapter Two is around the corner! A full week of The Journey Down releases from June 21st!  ...